January - 2021

top of page

Sage Group News

Squarex Announces End of Phase 2 Meeting with FDA for its Cold Sore Prevention Asset

Squarex Announces End of Phase 2 Meeting with FDA for its Cold Sore Prevention Asset

Squarex Announces End of Phase 2 Meeting with FDA for its Cold Sore Prevention Asset

Saint Paul, Minnesota, USA, 19 January 2021 – Squarex Pharma (SQX), a St. Paul, Minnesota, USA-based company, announced updated results...

Exhalation Technology Announces Updated Clinical Trial Data for its Rapid Covid-19 Diagnostic Test

Exhalation Technology Announces Updated Clinical Trial Data for its Rapid Covid-19 Diagnostic Test

Exhalation Technology Announces Updated Clinical Trial Data for its Rapid Covid-19 Diagnostic Test

Cambridge, England, 4 January 2021 – Exhalation Technology (ETL), a Cambridge, UK-based company, announced updated results from its...

bottom of page